The evaluation of HER2 discordance and heterogeneity in pancreas adenocarcinoma

被引：0
|
作者：
Han, S. [1 ]
机构：
[1] Dong A Univ, Coll Med, Dept Pathol, Busan, South Korea
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-21-011
引用
收藏
页码：S216 / S216
页数：1
相关论文
共 50 条
  • [21] Characterization of HER2 alterations in lung adenocarcinoma
    Dahake, Nikita
    Serebriiskii, Ilya
    Valerii, Pavlov
    Golemis, Erica
    Borghaei, Hossein
    Judd, Julia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] HER2/neu as target in gastric adenocarcinoma
    Cetin, Bulent
    Ozet, Ahmet
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 1
  • [23] Her2 Status in Small Intestinal Adenocarcinoma
    Chan, O. T. M.
    Chen, Z.
    Phan, D. C.
    Himmelfarb, E.
    Wang, H. L.
    MODERN PATHOLOGY, 2010, 23 : 140A - 140A
  • [24] Her2 Status in Small Intestinal Adenocarcinoma
    Chan, O. T. M.
    Chen, Z.
    Phan, D. C.
    Himmelfarb, E.
    Wang, H. L.
    LABORATORY INVESTIGATION, 2010, 90 : 140A - 140A
  • [25] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [26] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yang, Yi-ling
    Fan, Yu
    Lang, Rong-gang
    Gu, Feng
    Ren, Mei-Jing
    Zhang, Xin-Min
    Yin, Dong
    Fu, Li
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1095 - 1102
  • [27] The relationship between double minute amplification of HER2 and HER2 genetic heterogeneity in gastric cancer
    Kanayama, Kazuki
    Imai, Hiroshi
    Matsuda, Chise
    Hirokawa, Yoshifumi
    Watanabe, Masatoshi
    CANCER SCIENCE, 2022, 113
  • [28] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yi-ling Yang
    Yu Fan
    Rong-gang Lang
    Feng Gu
    Mei-Jing Ren
    Xin-Min Zhang
    Dong Yin
    Li Fu
    Breast Cancer Research and Treatment, 2012, 134 : 1095 - 1102
  • [29] Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
    Kosaka, Takayuki
    Tanizaki, Junko
    Paranal, Raymond M.
    Endoh, Hideki
    Lydon, Christine
    Capelletti, Marzia
    Repellin, Claire E.
    Choi, Jihyun
    Ogino, Atsuko
    Calles, Antonio
    Ercan, Dalia
    Redig, Amanda J.
    Bahcall, Magda
    Oxnard, Geoffrey R.
    Eck, Michael J.
    Janne, Pasi A.
    CANCER RESEARCH, 2017, 77 (10) : 2712 - 2721
  • [30] Case Series of HER2 Mutated Metastatic Lung Adenocarcinoma and Response to HER2 Targeted Therapies
    Chuang, Jody
    Neal, Joel W.
    Wakelee, Heather A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S549 - S549
12345